Inhibitory Effects of Phellinus linteus and Rice with Phellinus linteus Mycelium on Obesity and Diabetes |
Kim, Haeseop
(Haetteulnal Co., Ltd.)
You, Jeheon (Haetteulnal Co., Ltd.) Jo, Yeongcheol (Jeollanamdo Ocean & Fisheries Science Institute) Lee, Youngjae (Jeollanamdo Ocean & Fisheries Science Institute) Park, Inbae (Jeollanamdo Ocean & Fisheries Science Institute) Park, Jeongwook (Jeollanamdo Ocean & Fisheries Science Institute) Jung, Myung-A (Jellanamdo Institute of Natural Resources Research) Kim, Young-Suk (Jellanamdo Institute of Natural Resources Research) Kim, Sunoh (Jellanamdo Institute of Natural Resources Research) |
1 | Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of the low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502. |
2 | Ren G, Liu XY, Zhu HK, Yang SZ, Fu CX. 2006. Evaluation of cytotoxic activities of some medicinal polypore fungi from China. Fitoterapia 77: 408-410. DOI ScienceOn |
3 | Lee JW, Bang KW. 2001. Biological activity of Phellinus spp. Food Industry and Nutrition 6(1): 25-33. |
4 | Rubin CS, Hirsch A, Fung C, Rosen OM. 1978. Development of hormone receptors and hormonal responsiveness in vitro. Insulin receptors and insulin sensitivity in the preadipocyte and adipocyte forms of 3T3-L1 cells. J Biol Chem 253:7570-7578. |
5 | Kim JH, Son IS, Kim JS, Kim KH, Kwon CS. 2008. Lipaseinhibitory and anti-oxidative activity of the methanol extract and the powder of Phellinus linteus. J Korean Soc Food Sci Nutr 37: 154-161. DOI ScienceOn |
6 | Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C, Gresser MJ, Tremblay ML, Kennedy BP. 1999. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283: 1544-1548. DOI ScienceOn |
7 | Flier JS, Maratos-Flier E. 1998. Obesity and the hypothalamus: novel peptides for new pathways. Cell 92: 437-440. DOI ScienceOn |
8 | Després JP, Lemieux I. 2006. Abdominal obesity and metabolic syndrome. Nature 444: 881-887. DOI ScienceOn |
9 | Jornayvaz FR, Samuel VT, Shulman GI. 2010. The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. Annu Rev Nutr 30: 273-290. DOI ScienceOn |
10 | Kannel WB, Cupples LA, Ramaswami R, Stokes J 3rd, Kreger BE, Higgins M. 1991. Regional obesity and risk of cardiovascular disease; the Framingham study. J Clin Epidemiol 44: 183-190. DOI ScienceOn |
11 | Otto TC, Lane MD. 2005. Adipose development: from stem cell to adipocyte. Crit Rev Biochem Mol Biol 40: 229-242. DOI ScienceOn |
12 | Duntas LH. 2002. Thyroid disease and lipids. Tyroid 12:287-293. |
13 | Johnson TO, Ermolieff J, Jirousek MR. 2002. Protein tyrosine phosphatase 1B inhibitors for diabetes. Nat Rev Drug Discov 1: 696-709. DOI ScienceOn |
14 | Cook WS, Unger RH. 2002. Protein tyrosine phosphatase 1B: a potential leptin resistance factor of obesity. Dev Cell 2: 385-387. DOI ScienceOn |